 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
International News India: Ranbaxy Says Four More HIV Drugs Make It to WHO's Safe ListMay 26, 2006 On Wednesday, Indian pharmaceutical manufacturer Ranbaxy Laboratories Ltd. announced that four more of its generic drugs have been approved by the World Health Organization for treatment of HIV/AIDS in developing countries. The drugs approved are two variants of efavirenz and two variants of stavudine, each widely used in HIV treatment regimens in the developing world. Ranbaxy now has 12 of its drugs on the WHO list of safe HIV/AIDS medicines. The company's generic drugs are about 8-10 times cheaper than patented drugs. Associated Press 05.24.2006  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
|
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
